MedPath

Evaluating the effect of Vitamin E and Vitamin A on Chemotherapy-Induced Oral Mucositis

Phase 3
Completed
Conditions
Oral Mucositis.
Oral mucositis (ulcerative) due to antineoplastic therapy
K12.31
Registration Number
IRCT20210916052498N1
Lead Sponsor
Birjand University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
28
Inclusion Criteria

Chemotherapy’s indicated
No interactions between vitamins E and A and chemotherapy

Exclusion Criteria

Chemotherapy’s Contraindicated
Interactions between vitamins E and A and chemotherapy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Oral Mucositis. Timepoint: Days 1, 7, 14 and 21 after starting cancer treatment. Method of measurement: Clinical examination by a dentist based on World Health Organization oral mucositis grading scale.
Secondary Outcome Measures
NameTimeMethod
Pain severity. Timepoint: Days 1, 7, 14 and 21 after starting cancer treatment. Method of measurement: Visual Analogue Scale.
© Copyright 2025. All Rights Reserved by MedPath